Mechanisms linking hot flashes to cardiovascular risk
潮热与心血管风险的关联机制
基本信息
- 批准号:8183866
- 负责人:
- 金额:$ 57.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAffectAgeAlgorithmsAmbulatory ElectrocardiographyAtherosclerosisAttentionBehavioralBenignBlood PressureBlood specimenBody mass indexCardiacCardiovascular DiseasesCardiovascular systemCarotid ArteriesCause of DeathCessation of lifeCoagulation ProcessDevelopmentDiabetes MellitusEstradiolEstrogensEventFrequenciesFunctional disorderHealthHeartHeart DiseasesHemostatic AgentsHormonesHot flushesHourHypertensionInflammationInflammatoryInvestigationLinear RegressionsLinkLipidsMeasurementMeasuresMediatingMenopausal SymptomMenopauseModelingMonitorObesityParticipantPathway interactionsPatient Self-ReportPerimenopausePharmaceutical PreparationsPhysiologicalPhysiologyPostmenopauseProcessProgestinsQuality of lifeRelative (related person)RelianceReportingResearchResearch DesignResearch PersonnelRiskRisk FactorsSamplingSmokingSymptomsTestingTextThickUltrasonographyVasomotorWomanWomen&aposs HealthWorkagedbrachial arterycalcificationcardiovascular disorder riskcardiovascular risk factordesigndiariesexperienceheart rate variabilityimprovedindexingintima mediamenmiddle agemortalitynon-smokernovelnovel markerolder womenreproductivereproductive hormone
项目摘要
DESCRIPTION (provided by applicant): Two major health issues facing women as they age are cardiovascular disease (CVD) and menopausal hot flashes. CVD is the leading cause of death among women. Hot flashes are experienced by many midlife women, and for 30% of women, they are frequent or severe. Although hot flashes are traditionally regarded as a benign midlife symptom, recent research has linked a high burden of hot flashes to CVD risk. Several large trials have indicated that the greatest risk of cardiovascular events with hormone use appears concentrated among women reporting moderate to severe hot flashes. Our research shows elevated subclinical CVD among women reporting frequent hot flashes. Important mechanisms linking a high burden of hot flashes to CVD risk may be changes in endothelial function, inflammation/coagulation and cardiac vagal control. However, findings linking hot flashes to cardiovascular risk are just emerging. None of these studies was designed to examine associations between hot flashes and cardiovascular risk. Most have notable limitations, including the reliance upon crude, self-report measures of hot flashes vulnerable to multiple biases. The aim of this investigation is to examine whether women with daily hot flashes have adverse indicators of cardiovascular risk, including poorer endothelial function, higher carotid intima media thickness, lower cardiac vagal control, and an adverse inflammatory and hemostatic profile, relative to women without hot flashes. It is hypothesized that these differences will be independent of traditional CVD risk factors. Secondary aims include testing acute changes in cardiac vagal control during hot flashes and examining key pathways involved in these associations. The proposed sample includes 300 perimenopausal and postmenopausal women aged 40-60, half with daily hot flashes and half without hot flashes. Participants will be nonsmokers, free of heart disease and treated diabetes or hypertension, and free of medications impacting hot flashes. All women will undergo 3 days of physiologic hot flash monitoring, 24 hours of which will include ambulatory electrocardiography for measurement of cardiac vagal control (high frequency heart rate variability), a brachial artery ultrasound for measurement of endothelial function (flow mediated dilation), a carotid artery ultrasound for measurement of intima media thickness, and a blood sample for assessment of inflammatory/hemostatic markers and estradiol concentrations. Relations between hot flashes and cardiovascular risk indicators will be examined using linear regression and linear mixed models. This study represents the first study specifically designed to examine relations between hot flashes and CVD risk, and is an important first step in better understanding links between hot flashes and CVD risk. Addressing these aims may inform a better understanding of the physiology of hot flashes and support the development of a novel marker of cardiovascular risk among midlife women. This work has the potential to challenge the way that this presumably benign menopausal symptom is understood by researchers, clinicians, and women.
PUBLIC HEALTH RELEVANCE: This research is aimed at understanding whether and how menopausal hot flashes are linked to cardiovascular disease (CVD) risk. This work has the potential to change the way that this common midlife symptom has long been understood. This research may ultimately assist with CVD risk prediction among midlife women.
描述(由申请人提供):随着年龄的增长,女性面临的两大健康问题是心血管疾病(CVD)和更年期潮热。心血管疾病是妇女死亡的主要原因。许多中年女性都经历过潮热,30%的女性频繁或严重潮热。虽然传统上认为潮热是一种良性的中年症状,但最近的研究已经将潮热的高负担与CVD风险联系起来。几项大型试验表明,使用激素发生心血管事件的最大风险似乎集中在报告中度至重度潮热的女性身上。我们的研究表明,在报告频繁潮热的女性中,亚临床心血管疾病发生率升高。将潮热高负担与CVD风险联系起来的重要机制可能是内皮功能、炎症/凝血和心脏迷走神经控制的改变。然而,将潮热与心血管风险联系起来的研究结果才刚刚出现。这些研究都不是为了检验潮热和心血管风险之间的关系。大多数都有明显的局限性,包括依赖于对潮热的粗糙的自我报告测量,容易受到多重偏见的影响。本研究的目的是研究与没有潮热的女性相比,每日潮热的女性是否有心血管风险的不良指标,包括内皮功能较差、颈动脉内膜中层厚度较高、心脏迷走神经控制较低、炎症和止血不良。假设这些差异与传统的心血管疾病危险因素无关。次要目的包括检测潮热期间心脏迷走神经控制的急性变化,并检查涉及这些关联的关键途径。拟议的样本包括300名年龄在40-60岁之间的围绝经期和绝经后妇女,其中一半每天都有潮热,一半没有潮热。参与者将不吸烟,没有心脏病,没有接受过糖尿病或高血压治疗,没有服用影响潮热的药物。所有女性将接受3天的生生性潮热监测,其中24小时包括动态心电图测量心脏迷走神经控制(高频心率变异性),肱动脉超声测量内皮功能(血流介导的扩张),颈动脉超声测量内膜中膜厚度,血液样本用于评估炎症/止血标志物和雌二醇浓度。潮热与心血管危险指标之间的关系将采用线性回归和线性混合模型进行检验。这项研究是第一个专门研究潮热和心血管疾病风险之间关系的研究,是更好地理解潮热和心血管疾病风险之间联系的重要的第一步。解决这些问题可能有助于更好地理解潮热的生理学,并支持开发一种新的中年妇女心血管风险标志物。这项研究有可能挑战研究人员、临床医生和妇女对这种可能是良性的更年期症状的理解方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
REBECCA C THURSTON其他文献
REBECCA C THURSTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('REBECCA C THURSTON', 18)}}的其他基金
Project 2: Menopause, Midlife and Cardiovascular Health in Early Old Age
项目2:更年期、中年和早年心血管健康
- 批准号:
10471457 - 财政年份:2020
- 资助金额:
$ 57.35万 - 项目类别:
Project 2: Menopause, Midlife and Cardiovascular Health in Early Old Age
项目2:更年期、中年和早年心血管健康
- 批准号:
10263899 - 财政年份:2020
- 资助金额:
$ 57.35万 - 项目类别:
Interdisciplinary Mentoring and Research in Womens Cardiovascular Health
女性心血管健康的跨学科指导和研究
- 批准号:
10406174 - 财政年份:2014
- 资助金额:
$ 57.35万 - 项目类别:
Interdisciplinary Mentoring and Research in Womens Cardiovascular Health
女性心血管健康的跨学科指导和研究
- 批准号:
10646432 - 财政年份:2014
- 资助金额:
$ 57.35万 - 项目类别:
Interdisciplinary Mentoring and Research in Womens Cardiovascular Health
女性心血管健康的跨学科指导和研究
- 批准号:
8748446 - 财政年份:2014
- 资助金额:
$ 57.35万 - 项目类别:
Interdisciplinary Mentoring and Research in Womens Cardiovascular Health
女性心血管健康的跨学科指导和研究
- 批准号:
8913258 - 财政年份:2014
- 资助金额:
$ 57.35万 - 项目类别:
Interdisciplinary Mentoring and Research in Womens Cardiovascular Health
女性心血管健康的跨学科指导和研究
- 批准号:
10171410 - 财政年份:2014
- 资助金额:
$ 57.35万 - 项目类别:
Mechanisms linking hot flashes to cardiovascular risk
潮热与心血管风险的关联机制
- 批准号:
8701365 - 财政年份:2011
- 资助金额:
$ 57.35万 - 项目类别:
Mechanisms linking hot flashes to cardiovascular risk
潮热与心血管风险的关联机制
- 批准号:
8323938 - 财政年份:2011
- 资助金额:
$ 57.35万 - 项目类别:
Mechanisms linking hot flashes to cardiovascular risk
潮热与心血管风险的关联机制
- 批准号:
8512775 - 财政年份:2011
- 资助金额:
$ 57.35万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 57.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 57.35万 - 项目类别:
Operating Grants














{{item.name}}会员




